Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Ryan J. Watts Insider Profile
4 Followers
Ryan J. Watts, President & CEO, Director at Denali Therapeutics, holds 2.44M shares in Denali Therapeutics (Ticker: DNLI).
Ryan J. Watts Denali Therapeutics (DNLI)President & CEO, Director
Denali Therapeutics (DNLI)
President & CEO, Director
Ranked #68,261 out of 98,743 Corporate Insiders
Profitable Transactions
11 out of 21 Profitable Transactions
Average Return
-5.00%
Average return per transaction
Time Frame
Compare to
Insider Roles
President & CEO, Director
Roles that Ryan J. Watts holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Feb 16, 2021 - Feb 16, 2022
Return:+45.00%
The most profitable trade made by Ryan J. Watts
Ryan J. Watts's Trading History
List of latest transactions for each holding click on a transaction to see Ryan J. Watts's performance on stock
You May Also Like
Ryan J. Watts insider profile FAQ
What is the percentage of profitable transactions made by Ryan J. Watts?
The percentage of profitable transactions made by Ryan J. Watts is 52%.
What is the average return per transaction made by Ryan J. Watts?
The average return per transaction made by Ryan J. Watts is -5.00%.
What stocks does Ryan J. Watts hold?
Ryan J. Watts holds: DNLI stocks.
What was Ryan J. Watts’s latest transaction?
Ryan J. Watts latest transaction was an Uninformative Sell of ―.
What was Ryan J. Watts's most profitable transaction?
Ryan J. Watts’s most profitable transaction was an Informative Sell of DNLI stock on February 16, 2021. The return on the trade was 45.00%.
What is Ryan J. Watts's role in Denali Therapeutics?
Ryan J. Watts's role in Denali Therapeutics is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.